Skip to main content
DIRUI INDUSTRIAL CO.,LTD. logo

DIRUI INDUSTRIAL CO.,LTD. — Investor Relations & Filings

Ticker · 300396 ISIN · CNE100001XS7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,690 across all filing types
Latest filing 2015-10-14 Earnings Release
Country CN China
Listing Shenzhen Stock Exchange 300396

About DIRUI INDUSTRIAL CO.,LTD.

https://www.dirui.com.cn

DIRUI INDUSTRIAL CO.,LTD. specializes in the research, development, manufacturing, and distribution of medical laboratory instruments and diagnostic reagents. The company provides comprehensive solutions for in-vitro diagnostics (IVD), focusing on several key clinical areas including urinalysis, biochemistry, hematology, and chemiluminescence immunoassay. Its product portfolio features high-throughput automated analyzers and integrated laboratory systems designed to enhance diagnostic efficiency and accuracy. DIRUI serves a global market, providing medical institutions and laboratories with a wide range of diagnostic tools, from urine sediment analysis to vaginal secretion testing. The company emphasizes technological innovation and quality control to support clinical decision-making and patient care through reliable laboratory automation and standardized testing protocols.

Recent filings

Filing Released Lang Actions
2015年度前三季度业绩预告
Earnings Release Classification · 95% confidence The document is a performance forecast for the first three quarters of 2015, providing estimated net profit figures and growth percentages compared to the previous year. It explicitly states that the forecast has not been audited and that detailed financial data will be disclosed in the company's 2015 third quarter report. The document is an announcement of expected financial results rather than the actual financial report itself. This fits the definition of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights only. The document length is short and it provides preliminary performance estimates, not full financial statements or detailed analysis, so it is not an Interim/Quarterly Report (IR). Therefore, the correct classification is Earnings Release (ER). 9M 2015
2015-10-14 Chinese
关于使用自有闲置资金购买银行理财产品的进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by Changchun Dirui Medical Technology Co., Ltd. regarding the progress of using idle funds to purchase bank wealth management products. It details the amounts, types, expected yields, risks, and risk control measures related to these financial products. The document is an update on financing activities involving the company's capital management rather than a financial report or earnings release. It does not contain financial statements or earnings data but focuses on capital usage and investment activities. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is 2214 characters, which is consistent with an announcement rather than a full report.
2015-10-12 Chinese
关于持股5%以下股东减持股份计划的提示性公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding a shareholder's plan to reduce their shareholding below 5%. It details the shareholder's current holdings, the commitment to lock-up periods, the planned reduction amount, price conditions, and methods of reduction. The document is short (1300 characters) and focuses on shareholding changes by a significant shareholder but below 5%. It is not a financial report, earnings release, or management report. It fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds. The document is not an announcement of a report or a certification, so it is not RPA or RNS. Therefore, the correct classification is MRQ with high confidence.
2015-10-08 Chinese
关于取得发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from Changchun Dirui Medical Technology Co., Ltd. about the receipt of two invention patent certificates issued by the National Intellectual Property Administration of China. It includes details about the patents, their application dates, and their relevance to the company's core technology. The document is brief (710 characters) and does not contain any financial data, regulatory filings, or report references. It is an announcement related to intellectual property achievements rather than financial or governance reports. Therefore, it does not fit into categories like Annual Report, Interim Report, or Regulatory Filings. Given the content and length, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous announcements that do not fit other specific categories.
2015-09-29 Chinese
关于完成工商变更登记的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the completion of business registration changes, including updates to the company's articles of association and board size, and the issuance of a new business license. It does not contain financial statements, audit information, or detailed financial data. The document is relatively short (1100 characters) and focuses on regulatory and administrative updates rather than financial reporting or shareholder voting results. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2015-09-28 Chinese
国信证券股份有限公司关于公司首次公开发行股票2015年半年度跟踪报告
Interim / Quarterly Report Classification · 90% confidence The document is titled as a '2015年半年度跟踪报告' (2015 half-year tracking report) related to the initial public offering (IPO) of Changchun Dirui Medical Technology Co., Ltd. It is issued by Guosen Securities Co., Ltd., the sponsor institution. The content includes a review of sponsorship work, company governance, compliance with commitments, and other supervisory activities during the first half of 2015. The document contains substantive information about the company's operations, governance, and compliance during the half-year period, which aligns with the characteristics of an Interim / Quarterly Report. The document length is 2226 characters, which is relatively short but contains detailed substantive content rather than just an announcement or certification. Therefore, it should be classified as an Interim / Quarterly Report (IR). H1 2015
2015-09-09 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.